![](/img/cover-not-exists.png)
PCN127 COMPARISON OF PARTITIONED SURVIVAL VERSUS MARKOV COHORT MODELING APPROACHES IN THE EVALUATION OF COST-EFFECTIVENESS OF BLINATUMOMAB VERSUS CHEMOTHERAPY IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST HEMATOLOGICAL COMPLETE REMISSION WITH MINIMAL RESIDUAL DISEASE
Delea, T.E., Despiegel, N., Boyko, D., Dirnberger, F., Tiwana, S., Sapra, S.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.1617
Date:
May, 2020
File:
PDF, 378 KB
2020